Financials
- Market Capitalization 6.4 B
- Employee 258
- Founded 2014
- CEO N/A
- Website www.cogentbio.com
- Headquarter Delaware, United States
- FIGI BBG007DHZQR7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-16.44
Relación precio/flujo de caja
-637.59
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1156 | SRRK Scholar Rock Holding Corporation - Common Stock | 54.70 USD | -3.54% | -1.48% | +22.07% | +82.21% | 6.55 B USD | ||
| 1159 | XENE Xenon Pharmaceuticals Inc. - Common Shares | 67.72 USD | -1.74% | +10.83% | +29.88% | +66.02% | 6.55 B USD | ||
| 1186 | LQDA Liquidia Corporation - Common Stock | 71.21 USD | -8.62% | -10.15% | -0.03% | +215.09% | 6.33 B USD | ||
| 1198 | LGND Ligand Pharmaceuticals Incorporated - Common Stock | 309.25 USD | -2.21% | -2.80% | +21.27% | +65.27% | 6.20 B USD |